EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular cross-talk between long COVID-19 and Alzheimer’s disease

Magdalena Pszczołowska iD, Kamil Walczak, Weronika Misków, Katarzyna Antosz, Joanna Batko, Julia Karska, Jerzy Leszek

GeroScience · 2024

DOI: 10.1007/s11357-024-01096-1 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift GeroScience, 2024. Verfasst von Magdalena Pszczołowska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Wrocław Medical University, Wrocław, Poland. magdalena.pszczolowska@gmail.com. Hauptthemen laut MEDLINE: Alzheimer Disease, COVID-19. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 128 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The long COVID (coronavirus disease), a multisystemic condition following severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, is one of the widespread problems. Some of its symptoms affect the nervous system and resemble symptoms of Alzheimer’s disease (AD)—a neurodegenerative condition caused by the accumulation of amyloid beta and hyperphosphorylation of tau proteins. Multiple studies have found dependence between these two conditions. Patients with Alzheimer’s disease have a greater risk of SARS-CoV-2 infection due to increased levels of angiotensin-converting enzyme 2 (ACE2), and the infection itself promotes amyloid beta generation which enhances the risk of AD. Also, the molecular pathways are alike—misregulations in folate-mediated one-carbon metabolism, a deficit of Cq10, and disease-associated microglia. Medical imaging in both of these diseases shows a decrease in the volume of gray matter, global brain size reduction, and hypometabolism in the parahippocampal gyrus, thalamus, and cingulate cortex. In some studies, a similar approach to applied medication can be seen, including the use of amino adamantanes and phenolic compounds of rosemary. The significance of these connections and their possible application in medical practice still needs further study but there is a possibility that they will help to better understand long COVID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCOVID-19HumansSARS-CoV-2Post-Acute COVID-19 SyndromeAmyloid beta-PeptidesChronic Disease

Stichwörter der Autor:innen

Alzheimer’s diseaseDementiaFOCMLong COVIDMicrogliaSARS-CoV-2

Substanzen

Amyloid beta-Peptides

Autor:innen und Institutionen

  • Faculty of Medicine, Wrocław Medical University, Wrocław, Poland. magdalena.pszczolowska@gmail.com.
  • Faculty of Medicine, Wrocław Medical University, Wrocław, Poland.
  • Clinic of Psychiatry, Department of Psychiatry, Medical Department, Wrocław Medical University, Wrocław, Poland.

ORCID-Profile: Magdalena Pszczołowska

Zitieren

APA

Pszczołowska, M., Walczak, K., Misków, W., Antosz, K., Batko, J., Karska, J., & Leszek, J. (2024). Molecular cross-talk between long COVID-19 and Alzheimer’s disease. GeroScience. https://doi.org/10.1007/s11357-024-01096-1

Vancouver

Pszczołowska M, Walczak K, Misków W, Antosz K, Batko J, Karska J, et al. Molecular cross-talk between long COVID-19 and Alzheimer’s disease. GeroScience. 2024. doi:10.1007/s11357-024-01096-1

BibTeX
@article{Pszczoowska2024,
  author = {Pszczołowska, Magdalena and Walczak, Kamil and Misków, Weronika and Antosz, Katarzyna and Batko, Joanna and Karska, Julia and Leszek, Jerzy},
  title = {Molecular cross-talk between long COVID-19 and Alzheimer’s disease},
  journal = {GeroScience},
  year = {2024},
  doi = {10.1007/s11357-024-01096-1}
}
Kostenlos starten →